Question 1

EXAS vs MRK: which stock scores better overall?

Accepted Answer

Based on Q·Score, Merck & Company, Inc. (MRK) scores 6.7/10 versus Exact Sciences Corporation (EXAS) at 4.7/10. The Q·Score measures five dimensions: Quality, Value, Growth, Safety, and Momentum. For informational purposes only — not financial advice.

Question 2

Which has better revenue growth: EXAS or MRK?

Accepted Answer

Exact Sciences Corporation (EXAS) scores higher on Growth (6.5/10 vs 6.2/10). Exact Sciences Corporation reports revenue growth (23.1% YoY) while Merck & Company, Inc. reports (4.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.

Question 3

Is EXAS or MRK more attractively valued?

Accepted Answer

Merck & Company, Inc. (MRK) scores higher on Value (7.2/10 vs 4.2/10). EXAS trades at 55.2× P/E versus MRK at 11.5×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.

Question 4

What do analysts say about EXAS vs MRK?

Accepted Answer

There are 10 analysts covering EXAS with a consensus price target of $106.30, and 27 analysts covering MRK with a consensus target of $129.74. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.

Question 5

Which is more profitable: EXAS or MRK?

Accepted Answer

Merck & Company, Inc. (MRK) scores higher on Quality (6.2/10 vs 2.9/10). Net profit margin: EXAS at -6.4%, MRK at 13.6%. Quality scores reflect profit margins, return on equity, and free cash flow generation.

Question 6

Which has stronger financial health: EXAS or MRK?

Accepted Answer

Merck & Company, Inc. (MRK) scores higher on Financial Health (7/10 vs 6.9/10). Market beta: EXAS at 1.44, MRK at 0.28. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.

Question 7

What are the market caps of EXAS and MRK?

Accepted Answer

Exact Sciences Corporation (EXAS) has a market capitalisation of $20.0B, while Merck & Company, Inc. (MRK) has a market cap of $277.0B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.

Question 8

Do EXAS or MRK pay dividends?

Accepted Answer

EXAS does not currently pay a dividend, while MRK pays a dividend yield of 3.03%. Dividend yields fluctuate with share price and company payout decisions.

Exact Sciences Corporation vs Merck & Company, Inc. — Stock Comparison

Q·Score Breakdown

Analyst Consensus

Fundamentals